Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: J Endocrinol. 2020 Jan;244(1):237–247. doi: 10.1530/JOE-19-0259

Figure 6. Effect of TTA-P2 on Angiotensin II (Ang II) - or high K+- stimulated aldosterone secretion from human adrenal slices.

Figure 6.

A, TTA-P2 abrogates Ang II-stimulated aldosterone secretion from human adrenal slices. B, Statistical analysis of TTA-P2 induced inhibition of Ang II-stimulated aldosterone secretion. Data are presented as fold over control. *, P < 0.05 compared with control. #, p < 0.05 compared with Ang II alone (n = 4). C, TTA-P2 abrogates high K+-stimulated aldosterone secretion from human adrenal slices. D, Statistical analysis of TTA-P2 induced inhibition of high K+-stimulated aldosterone secretion. *, p < 0.05 compared with control.#, p < 0.05 compared with high K+ alone (n = 5).